CUSIP: 92189F387
Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SHRT HGH YLD MUN
-
Total 13F shares
-
9,396,480
-
Share change
-
+436,551
-
Total reported value
-
$211,258,799
-
Price per share
-
$22.48
-
Number of holders
-
125
-
Value change
-
+$9,751,547
-
Number of buys
-
68
-
Number of sells
-
46
Security key
92189F387
Report period
Q4 2024
Institutions
125
Top holders
10
Reporting periods
Holder history for CUSIP 92189F387
Recent filing periods:
Top shareholders of SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) as of Q4 2024
As of 31 Dec 2024,
VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,396,480 shares.
The largest 10 holders included
ENVESTNET ASSET MANAGEMENT INC, MERCER GLOBAL ADVISORS INC /ADV, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, LPL Financial LLC, COMMONWEALTH EQUITY SERVICES, LLC, Dakota Wealth Management, Fragasso Financial Advisors Inc, and UBS Group AG.
This page lists
125
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor |
Q3 2024 Shares |
Q4 2024 Shares |
Share Diff |
Share Chg % |
Q3 2024 Value $ |
Q4 2024 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.